当前位置:首页 - 行情中心 - 佐力药业(300181) - 财务分析

佐力药业

(300181)

  

流通市值:87.29亿  总市值:101.84亿
流通股本:6.01亿   总股本:7.01亿

佐力药业(300181)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年第一季度实现净利润1.44亿元,每股收益0.20元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年第一季度最新股东权益290923.03万元,未分配利润87666.63万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年第一季度最新总资产386464.86万元,负债95541.83万元。

利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入672,899,096.571,942,440,446.031,464,947,132.51,011,458,568.59
营业总成本519,085,030.361,577,626,225.741,188,305,385.08820,542,149.95
营业利润176,428,413.24448,706,983.13337,410,309.54229,144,351.39
利润总额166,285,147.19446,641,758.36336,223,659.53228,710,483.41
净利润144,106,493.76390,762,921.66292,583,698.54201,775,194.53
其他综合收益-8,822,828.12-159,481,204.12-121,960,107-94,680,776.37
综合收益总额135,283,665.64231,281,717.54170,623,591.54107,094,418.16
资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计2,255,006,929.172,056,469,895.911,960,375,910.351,943,692,225.89
非流动资产合计1,609,641,697.881,570,569,074.61,583,094,879.371,605,008,332.33
资产总计3,864,648,627.053,627,038,970.513,543,470,789.723,548,700,558.22
流动负债合计901,185,580.04794,825,470.4754,873,040.4813,081,074.86
非流动负债合计54,232,733.2158,266,851.9575,309,227.1685,860,134.58
负债合计955,418,313.25853,092,322.35830,182,267.56898,941,209.44
归属于母公司股东权益合计2,862,996,929.342,728,743,064.492,667,380,677.872,603,411,549.83
股东权益合计2,909,230,313.82,773,946,648.162,713,288,522.162,649,759,348.78
负债和股东权益合计3,864,648,627.053,627,038,970.513,543,470,789.723,548,700,558.22
现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计551,331,352.32,175,128,909.961,634,268,265.691,082,385,225.59
经营活动现金流出小计534,263,902.261,886,667,871.51,410,316,284.08959,193,372.8
经营活动产生的现金流量净额17,067,450.04288,461,038.46223,951,981.61123,191,852.79
投资活动现金流入小计150,653,826.1149,138,635.5141,035,51832,003,747.92
投资活动现金流出小计76,493,139.62312,714,575.89156,183,883.94124,970,964.47
投资活动产生的现金流量净额74,160,686.49-263,575,940.38-115,148,365.94-92,967,216.55
筹资活动现金流入小计69,400,000269,699,428.54265,369,428.54207,469,428.54
筹资活动现金流出小计92,042,770.73429,019,452.4436,048,330.42354,557,265.03
筹资活动产生的现金流量净额-22,642,770.73-159,320,023.86-170,678,901.88-147,087,836.49
汇率变动对现金及现金等价物的影响9.1114.25222.65260
现金及现金等价物净增加额68,585,374.9-134,434,811.53-61,875,063.56-116,862,940.25
期末现金及现金等价物余额997,076,059.8928,144,392.891,000,704,140.86945,716,264.17
最新报告期:2024-04-21
研究机构分析师预测每股收益(元)更新日
2023年2024年2025年
光大证券黄素青0.780.951.162024-04-21
东方财富证券何玮0.710.891.092024-04-19
长城证券刘鹏0.710.86--2024-04-09
东吴证券徐梓煜,朱国广0.550.770.962024-04-01
长城证券刘鹏0.550.710.862024-03-11
TOP↑